Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
The State University of New York at Stony Brook is New York’s flagship university and No. 1 public university. Home to groundbreaking research, world-class education, and innovative healthcare. Where bold ideas thrive, and future leaders emerge.
Please show respect for your fellow users by maintaining a civil discussion. Comments are subject to the Terms of Use and Code of Conduct applicable to the social media employed.
Stony Brook University reserves the right to remove comments on Stony Brook University-run social media pages that unlawfully harass or discriminate; advocate illegal activity; incite violence; threaten; would be reasonably understood to instill fear or intimidate; contain spam; are clearly off-topic; are excessive in frequency; infringe on copyrights or trademarks; or publicly share private or identifying information about an individual. The University does not permit messages selling products or promoting commercial, political or other ventures. We reserve the right to take appropriate action when content that violates University policies or laws is brought to our attention.
The University does not permit messages selling products or promoting commercial, political or other ventures. We reserve the right to take appropriate action when content that violates University policies or laws is brought to our attention. Additionally, election campaign materials or postings deemed inappropriate will be deleted by the page administrators.
Stony Brook University is not affiliated with the ownership of the social media services listed above, nor does the University endorse them. Each service maintains its own privacy policy, terms of service, privacy statement, and other relevant policies that users must agree to in order to use the service. Stony Brook University is not responsible for your use of these sites. Please refer to our social media guidelines for additional guidance and best practices.
We are rebuilding biotech for the AI era.
When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific data and AI are built into how science gets done.
Benchling is the AI platform for biotech R&D. Scientists use Benchling to design experiments, capture structured data, and run AI agents and models directly in their workflows. Over 200,000 scientists around the world trust Benchling to power their most important work, from academic labs to Sanofi, Moderna, and more than half of the world's top 50 biopharma.